Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

actavis pharma, inc. - raloxifene hydrochloride (unii: 4f86w47br6) (raloxifene - unii:yx9162eo3i) - raloxifene hydrochloride 60 mg

Īrija - angļu - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - raloxifene - film-coated tablet - 60 milligram(s) - selective estrogen receptor modulators; raloxifene

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

stat rx usa - propoxyphene napsylate (unii: 38m219l1oj) (propoxyphene - unii:s2f83w92tk) - propoxyphene napsylate 100 mg - darvon-n is indicated for the relief of mild to moderate pain. darvon-n is contraindicated in patients with known hypersensitivity to propoxyphene. darvon-n is contraindicated in patients with significant respiratory depression (in unmonitored settings or the absence of resuscitative equipment) and patients with acute or severe asthma or hypercarbia. darvon-n is contraindicated in any patient who has or is suspected of having paralytic ileus. darvon-n is a schedule iv narcotic under the u.s. controlled substances act. darvon-n can produce drug dependence of the morphine type, and therefore, has the potential for being abused. psychic dependence, physical dependence and tolerance may develop upon repeated administration. darvon-n should be prescribed and administered with the same degree of caution appropriate to the use of other narcotic-containing medications. since darvon-n is a mu-opioid agonist, it may be subject to misuse, abuse, and addiction. addiction to opioids prescribed for pain manageme

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

kaiser foundation hospitals - raloxifene hydrochloride (unii: 4f86w47br6) (raloxifene - unii:yx9162eo3i) - raloxifene hydrochloride 60 mg

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

kaiser foundation hospitals - raloxifene hydrochloride (unii: 4f86w47br6) (raloxifene - unii:yx9162eo3i) - raloxifene hydrochloride 60 mg

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

avera mckennan hospital - raloxifene hydrochloride (unii: 4f86w47br6) (raloxifene - unii:yx9162eo3i) - raloxifene hydrochloride 60 mg

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

avera mckennan hospital - raloxifene hydrochloride (unii: 4f86w47br6) (raloxifene - unii:yx9162eo3i) - raloxifene hydrochloride 60 mg

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

prasco laboratories - raloxifene hydrochloride (unii: 4f86w47br6) (raloxifene - unii:yx9162eo3i) - raloxifene hydrochloride 60 mg

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

kaiser foundation hospitals - raloxifene hydrochloride (unii: 4f86w47br6) (raloxifene - unii:yx9162eo3i) - raloxifene hydrochloride 60 mg

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

strides pharma science pty ltd - raloxifene hydrochloride, quantity: 60 mg - tablet, film coated - excipient ingredients: polysorbate 80; magnesium stearate; hypromellose; crospovidone; citric acid monohydrate; microcrystalline cellulose; titanium dioxide; macrogol 400; povidone - raloxifene is indicated for the prevention and treatment of osteoporosis in post-menopausal women.